Medications

FDA skeptical of benefits from experimental ALS drug

Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.

Neuroscience

A digital reconstruction of the brain's power source

The EPFL Blue Brain Project has created the first digital reconstruction of the Neuro-Glia-Vascular Architecture providing a new framework to study brain function in health and disease. The study, published in Cerebral Cortex, ...

Arthritis & Rheumatism

An experimental vaccine against rheumatoid arthritis

Researchers at The University of Toledo have developed an experimental vaccine that shows significant promise in preventing rheumatoid arthritis, a painful autoimmune disease that cannot currently be cured.

Medications

New drug shows real promise against celiac disease

An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found—raising hopes that it could become the first medication for the serious digestive disorder.

page 6 from 34